The majority of miR-Es scored around zero, thereby indicating no significant effect of Dox-mediated protease targeting with combined PI3K-inhibitor treatment on relative miR-E representation and hence breast cancer cell viability or growth. This evidence concerns the gene PIK3CA and breast carcinoma.